147 related articles for article (PubMed ID: 8161932)
1. Interstitial deletion of 9q revisited.
Kwong YL; Ha SY; Ching LM; Chan LC
Leuk Lymphoma; 1993 Dec; 12(1-2):153-5. PubMed ID: 8161932
[TBL] [Abstract][Full Text] [Related]
2. Interstitial 9q- deletion in a case of acute myeloid leukemia-M2 arising from a granulocytic sarcoma.
Lunde JH; Allen EF
Cancer Genet Cytogenet; 1994 Dec; 78(2):239-41. PubMed ID: 7828160
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
4. Interstitial deletion of the long arm of chromosome 9 as the sole anomaly in acute myeloid leukaemia is associated with dyserythropoiesis.
Kwong YL; Chan TK; Chan LC
Leukemia; 1992 Jan; 6(1):64-5. PubMed ID: 1736015
[No Abstract] [Full Text] [Related]
5. Concomitant presence of trisomy 21 and del(9q) in acute myeloid leukemia.
Kwong YL; Chan LC
Cancer Genet Cytogenet; 1992 Nov; 64(1):92-4. PubMed ID: 1458456
[TBL] [Abstract][Full Text] [Related]
6. Del (9q) AML: clinical and cytological characteristics and prognostic implications.
Peniket A; Wainscoat J; Side L; Daly S; Kusec R; Buck G; Wheatley K; Walker H; Chatters S; Harrison C; Boultwood J; Goldstone A; Burnett A
Br J Haematol; 2005 Apr; 129(2):210-20. PubMed ID: 15813849
[TBL] [Abstract][Full Text] [Related]
7. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
[TBL] [Abstract][Full Text] [Related]
8. A case of M2 acute myeloblastic leukemia associated with an interstitial 9q deletion.
Lin CC; De Braekeleer M; Etches WS; Thay TY
Cancer Genet Cytogenet; 1987 Jan; 24(1):177-80. PubMed ID: 3466670
[TBL] [Abstract][Full Text] [Related]
9. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
[TBL] [Abstract][Full Text] [Related]
10. Deletion 9q as the sole karyotypic abnormality in myelocytic disorders: a new case of myelodysplastic syndrome and its prognostic implications in acute myelocytic leukemia.
Wan TS; Ma ES; Lam CC; Chan LC; Lee KK; Au WY
Cancer Genet Cytogenet; 2003 Sep; 145(2):184-6. PubMed ID: 12935935
[No Abstract] [Full Text] [Related]
11. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
[TBL] [Abstract][Full Text] [Related]
12. Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage.
Ferrara F; Scognamiglio M; Di Noto R; Schiavone EM; Poggi V; Fiorillo A; Libertini R; Vicari L; Del Vecchio L; Sebastio L
Leukemia; 1996 Dec; 10(12):1990-2. PubMed ID: 8946942
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
[TBL] [Abstract][Full Text] [Related]
14. Two different karyotypes with 1q abnormalities in a patient with Fanconi anemia.
Oliveira NI; Ribeiro EM; Raimondi SC; Bittencourt MA; Pasquini R; Cavalli IJ
Leuk Res; 2002 Nov; 26(11):1047-9. PubMed ID: 12363475
[TBL] [Abstract][Full Text] [Related]
15. Secondary acute myelogenous leukemia (AML) with trisomy 10 and del(9q) following precursor B-cell acute lymphoblastic leukemia (ALL) with a hyperdiploid karyotype.
Al-Tahou K; Jamil S; Mody R; Knaus A; Micale M; Huang J
Cancer Genet; 2012 Oct; 205(10):533-6. PubMed ID: 22944559
[TBL] [Abstract][Full Text] [Related]
16. del(16)(q22) in a child with acute myeloid leukemia without bone marrow eosinophilia.
Kawachi T; Nakamura H; Sadamori N; Tomonaga M; Kamihira S; Maeda H; Tsuji Y
Cancer Genet Cytogenet; 1992 Mar; 59(1):86-8. PubMed ID: 1555197
[No Abstract] [Full Text] [Related]
17. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome.
Wan TS; Au WY; Chan JC; Chan LC; Ma SK
Leuk Res; 1999 Nov; 23(11):1079-83. PubMed ID: 10576514
[TBL] [Abstract][Full Text] [Related]
18. Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.
Naarmann-de Vries IS; Sackmann Y; Klein F; Ostareck-Lederer A; Ostareck DH; Jost E; Ehninger G; Brümmendorf TH; Marx G; Röllig C; Thiede C; Crysandt M
Leuk Res; 2019 Jan; 76():15-23. PubMed ID: 30476680
[TBL] [Abstract][Full Text] [Related]
19. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
20. Interstitial 9q deletion in T-lymphoid/myeloid biphenotypic leukaemia.
Akashi K; Shibuya T; Harada M; Oogami A; Teshima T; Takamatsu Y; Kikuchi M; Niho Y
Br J Haematol; 1992 Feb; 80(2):172-7. PubMed ID: 1550772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
